NSD2 and plasma cell myeloma: Consistently, in multiple myeloma, t(4;14) chromosomal translocation resulting in NSD2 overexpression led to the aberrant accumulation of H3K36me2 at both the intragenic and intergenic regions, supporting the widespread targeting of NSD2 (Kuo et al. 2011; Popovic et al. 2014).